XENOMICS FILES NEW TR-DNA PATENT

Xenomics, a developer of next-generation medical DNA technologies, has announced that it has filed a U.S. patent application demonstrating the effectiveness of its non-invasive Transrenal-DNA technology in the diagnosis of parasite-caused infectious diseases such as malaria and leishmaniasis. Malaria and other parasite diseases infect hundreds of millions of people worldwide, and kill millions each year, many of them children.
Yahoo News